Additionally, both derivatives significantly reduced the protein expression of phosphorylated p38MAPK and COX-2, ameliorated oxidative stress by reducing MDA and restoring enzymatic antioxidants, SOD, and improved the histopathological features of synovitis compared to indomethacin as a standard drug. The gene discussed is PTGS2; the disease is synovitis.